North America Pharmaceutical Intermediates Market
No. of Pages: 115 | Report Code: TIPRE00025456 | Category: Life Sciences
No. of Pages: 115 | Report Code: TIPRE00025456 | Category: Life Sciences
North America consists of three major countries, namely the US, Canada, Mexico. The market is also evaluated for the Rest of the North American market. The growth of the market in countries such as the US and Canada is driven by the factors such as increasing demand for pharmaceutical intermediate to produce APIs, growing support supports through an initiative to enhance pharmaceutical production, and rising research and development for the biopharmaceutical industry. Also, the growing pharmaceutical industry in a country like Mexico is expected to serve the market's growth opportunities during the forecast period. The US is the largest market for pharmaceutical intermediates at a global level. The market's growth is attributed to increasing product development, increasing production of generic pharmaceutical production, and growing government support to enhance pharmaceutical and biopharmaceutical industries. In addition, the growing incidences of chronic and acute diseases have led to the growth of the market indirectly. Increased prevalence of chronic diseases and infectious diseases is the major factor driving the growth of the North America pharmaceutical intermediates market.
North America has been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 31,990,143, with 576,298 deaths reported in the US as of April 2021. The cases are also increasing in Mexico and Canada. In Mexico, the cases have reached 2,281,840, with 209,702deaths as of April 2021. Similarly, in Canada, there are about 1,071,016 COVID cases, reported as of April 2021. The pandemic is straining public health systems globally, interrupting and delaying many kinds of critical health care. A recent survey by the World Health Organization found that health services are among the most frequently disrupted. 7 in 10 countries around the world are experiencing disruptions along with United states, Canada and Mexico. However, as per the IRI data, demand for various dietary supplements rushed at the onset of the coronavirus pandemic in the U.S. at unprecedented rates. The total supplement sales increased by 6% during the first week of March, 2020. Also, due to social distancing practices consumers are experiencing changes to their daily routines of grooming and skin care. This has led to an increased demand for nutrition products that can be used at home. Also, the rising incidence of COVID patients has increased the demand for analgesics in the North America region.
Strategic insights for the North America Pharmaceutical Intermediates provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 11,054.47 Million |
| Market Size by 2028 | US$ 14,927.32 Million |
| Global CAGR (2021 - 2028) | 4.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
The geographic scope of the North America Pharmaceutical Intermediates refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The pharmaceutical intermediates market in North America is expected to grow from US$ 11,054.47 million in 2021 to US$ 14,927.32 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028. Countries such as Mexico is emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Low manufacturing and operating costs in the country are key factors driving the pharmaceutical manufacturing business in the region. Recent growth in the pharmaceutical industry indicate a positive outlook for the pharmaceutical intermediates market. Flourishing domestic pharmaceutical market in the region and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities, further boosting the growth of the market. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical manufacturing companies across North America region.
The North America pharmaceutical intermediates market is segmented on the bases of type, application, distribution channel, and country. Based on type, the market is segmented into GMP and Non GMP. The GMP segment dominated the market in 2020 is expected to be the fastest growing during the forecast period. On the basis of application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The others segment dominated the market in 2020 and vitamins segment is expected to be the fastest growing during the forecast period. On the basis of distribution channel, the pharmaceutical intermediates market is segmented into distributor and direct sales. The direct sales segment dominated the market in 2020 and distributor segment is expected to be the fastest growing during the forecast period.
A few major primary and secondary sources referred to for preparing this report on the pharmaceutical intermediates market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; chiracon GmbH; Codexis; Dishman Carbogen Amcis Ltd; Midas Pharma GmbH; Pfizer Inc.; Sanofi; Vertellus Holdings LLC are among others.
The North America Pharmaceutical Intermediates Market is valued at US$ 11,054.47 Million in 2021, it is projected to reach US$ 14,927.32 Million by 2028.
As per our report North America Pharmaceutical Intermediates Market, the market size is valued at US$ 11,054.47 Million in 2021, projecting it to reach US$ 14,927.32 Million by 2028. This translates to a CAGR of approximately 4.4% during the forecast period.
The North America Pharmaceutical Intermediates Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pharmaceutical Intermediates Market report:
The North America Pharmaceutical Intermediates Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Pharmaceutical Intermediates Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Pharmaceutical Intermediates Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Pharmaceutical Intermediates Market
